Polycystic Ovarian Syndrome: Is It Time to Rename PCOS to HA-PODS?
March 2016
in “
The Journal of Obstetrics and Gynecology of India
”
Polycystic Ovarian Syndrome PCOS Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome HA-PODS hyperandrogenism metabolic derangements Rotterdam 2003 AES 2006 NIH 1990 type 2 diabetes mellitus impaired glucose tolerance metabolic syndrome depressive disorders type 2 diabetes glucose intolerance depression
TLDR The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.
The 2016 review article proposed renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) to better reflect the condition's characteristics. The term PCOS was deemed misleading as it inaccurately suggests the presence of ovarian cysts and fails to represent the hyperandrogenism and metabolic derangements associated with the condition. The article also highlighted inconsistencies in the diagnostic criteria for PCOS across different statements, such as the Rotterdam 2003, AES 2006, and NIH 1990. The proposed name, HA-PODS, was aimed at facilitating diagnosis, treatment, and research consistency. The document also discussed the prevalence and risk factors of type 2 diabetes mellitus, impaired glucose tolerance, metabolic syndrome, and depressive disorders in women with PCOS. However, no conclusion was reached on a new name for PCOS, indicating ongoing discussion in the scientific community.
